Sagimet Biosciences (SGMT) Cash & Equivalents (2022 - 2026)
Sagimet Biosciences (SGMT) posted Cash & Equivalents of $165.9 million for Q2 2026, up 291.9% from $42.33 million a year earlier and up 352.9% from the prior quarter.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Sagimet Biosciences' Cash & Equivalents came in at $35.02 million, down 53.8% from FY2024.
- Annual Cash & Equivalents shows a three-year compound annual growth rate of 459.5% (FY2022 to FY2025).
- In prior years, Sagimet Biosciences' Cash & Equivalents was $75.84 million in FY2024 (+0.9%), $75.14 million in FY2023 and $200,000 in FY2022.
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q1 2024.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 0.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2024, with growth of 418.5%; the weakest was Q1 2025, with a decline of 63.4%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $36.63 million (Q1 2026), $35.02 million (Q4 2025) and $32.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Sagimet Biosciences | 497.68 Mn | 497.68 Mn | - | 165.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.90 Mn |
| Mar 31, 2026 | 36.63 Mn |
| Dec 31, 2025 | 35.02 Mn |
| Sep 30, 2025 | 32.50 Mn |
| Jun 30, 2025 | 42.33 Mn |
| Mar 31, 2025 | 64.72 Mn |
| Dec 31, 2024 | 75.84 Mn |
| Sep 30, 2024 | 77.01 Mn |
| Jun 30, 2024 | 95.96 Mn |
| Mar 31, 2024 | 176.78 Mn |
| Dec 31, 2023 | 75.14 Mn |
| Sep 30, 2023 | 101.84 Mn |
| Jun 30, 2023 | 18.51 Mn |
| Dec 31, 2022 | 200,000.00 |
API Access
Sagimet Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();